Clinical Trial Update: Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on switching from imiglucerase to plant cell expressed recombinant human glucocerebrosidase in Gaucher disease; status completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Imiglucerase (imiglucerase)
• Plant cell expressed recombinant human glucocerebrosidase

Snippet

Sponsor: Pfizer | Conditions: Gaucher Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-06-05